APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Hemostatic Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Topical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchTopical Hemostatic Agents Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Hemostatic Agents Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Topical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Hemostatic Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Hemostatic Agents Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Topical Hemostatic Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Hemostatic Agents include Pfizer, B Braun Melsungen, Baxter International, Vascular Solutions, The Medicines Company, Marine Polymer Technologies, Integra LifeSciences, Gelita Medical and Ethicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Topical Hemostatic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Hemostatic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Hemostatic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Hemostatic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Topical Hemostatic Agents Segment by Company

Pfizer

B Braun Melsungen

Baxter International

Vascular Solutions

The Medicines Company

Marine Polymer Technologies

Integra LifeSciences

Gelita Medical

Ethicon

Equimedical

C. R. Bard

Anika Therapeutics

Advanced Medical Solutions

Topical Hemostatic Agents Segment by Type

Gelation Sponge

Oxidized Regenerated Cellulose Based Hemostats

Others

Topical Hemostatic Agents Segment by Application

Hospitals

Nursing Homes

Surgical Centers

Topical Hemostatic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Topical Hemostatic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Topical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Topical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Topical Hemostatic Agents Industry Trends Table 2. Topical Hemostatic Agents Industry Drivers Table 3. Topical Hemostatic Agents Industry Opportunities and Challenges Table 4. Topical Hemostatic Agents Industry Restraints Table 5. Global Topical Hemostatic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Topical Hemostatic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Topical Hemostatic Agents Sales Market Share by Manufacturers Table 9. Global Topical Hemostatic Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Topical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Topical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Topical Hemostatic Agents Manufacturers, Product Type & Application Table 13. Global Topical Hemostatic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Topical Hemostatic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gelation Sponge Table 17. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats Table 18. Major Manufacturers of Others Table 19. Global Topical Hemostatic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 21. Global Topical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 22. Global Topical Hemostatic Agents Sales Market Share by Type (2021-2026) Table 23. Global Topical Hemostatic Agents Sales Market Share by Type (2027-2032) Table 24. Global Topical Hemostatic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Topical Hemostatic Agents Revenue by Type (2021-2026) & (K Units) Table 26. Global Topical Hemostatic Agents Revenue by Type (2027-2032) & (K Units) Table 27. Global Topical Hemostatic Agents Revenue Market Share by Type (2021-2026) Table 28. Global Topical Hemostatic Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Nursing Homes Table 31. Major Manufacturers of Surgical Centers Table 32. Global Topical Hemostatic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 34. Global Topical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 35. Global Topical Hemostatic Agents Sales Market Share by Application (2021-2026) Table 36. Global Topical Hemostatic Agents Sales Market Share by Application (2027-2032) Table 37. Global Topical Hemostatic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Topical Hemostatic Agents Revenue by Application (2021-2026) & (K Units) Table 39. Global Topical Hemostatic Agents Revenue by Application (2027-2032) & (K Units) Table 40. Global Topical Hemostatic Agents Revenue Market Share by Application (2021-2026) Table 41. Global Topical Hemostatic Agents Revenue Market Share by Application (2027-2032) Table 42. Global Topical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Topical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Topical Hemostatic Agents Sales Market Share by Region (2021-2026) Table 45. Global Topical Hemostatic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Topical Hemostatic Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 49. North America Topical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 50. Europe Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 52. Europe Topical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Topical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Topical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Topical Hemostatic Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Topical Hemostatic Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Topical Hemostatic Agents Revenue Market Share by Region (2021-2026) Table 63. Global Topical Hemostatic Agents Revenue Market Share by Region (2027-2032) Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pfizer Topical Hemostatic Agents Product Portfolio Table 68. Pfizer Recent Development Table 69. B Braun Melsungen Company Information Table 70. B Braun Melsungen Business Overview Table 71. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. B Braun Melsungen Topical Hemostatic Agents Product Portfolio Table 73. B Braun Melsungen Recent Development Table 74. Baxter International Company Information Table 75. Baxter International Business Overview Table 76. Baxter International Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Baxter International Topical Hemostatic Agents Product Portfolio Table 78. Baxter International Recent Development Table 79. Vascular Solutions Company Information Table 80. Vascular Solutions Business Overview Table 81. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Vascular Solutions Topical Hemostatic Agents Product Portfolio Table 83. Vascular Solutions Recent Development Table 84. The Medicines Company Company Information Table 85. The Medicines Company Business Overview Table 86. The Medicines Company Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. The Medicines Company Topical Hemostatic Agents Product Portfolio Table 88. The Medicines Company Recent Development Table 89. Marine Polymer Technologies Company Information Table 90. Marine Polymer Technologies Business Overview Table 91. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio Table 93. Marine Polymer Technologies Recent Development Table 94. Integra LifeSciences Company Information Table 95. Integra LifeSciences Business Overview Table 96. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Integra LifeSciences Topical Hemostatic Agents Product Portfolio Table 98. Integra LifeSciences Recent Development Table 99. Gelita Medical Company Information Table 100. Gelita Medical Business Overview Table 101. Gelita Medical Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Gelita Medical Topical Hemostatic Agents Product Portfolio Table 103. Gelita Medical Recent Development Table 104. Ethicon Company Information Table 105. Ethicon Business Overview Table 106. Ethicon Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Ethicon Topical Hemostatic Agents Product Portfolio Table 108. Ethicon Recent Development Table 109. Equimedical Company Information Table 110. Equimedical Business Overview Table 111. Equimedical Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Equimedical Topical Hemostatic Agents Product Portfolio Table 113. Equimedical Recent Development Table 114. C. R. Bard Company Information Table 115. C. R. Bard Business Overview Table 116. C. R. Bard Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. C. R. Bard Topical Hemostatic Agents Product Portfolio Table 118. C. R. Bard Recent Development Table 119. Anika Therapeutics Company Information Table 120. Anika Therapeutics Business Overview Table 121. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Anika Therapeutics Topical Hemostatic Agents Product Portfolio Table 123. Anika Therapeutics Recent Development Table 124. Advanced Medical Solutions Company Information Table 125. Advanced Medical Solutions Business Overview Table 126. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio Table 128. Advanced Medical Solutions Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Topical Hemostatic Agents Distributors List Table 132. Topical Hemostatic Agents Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Topical Hemostatic Agents Product Image Figure 2. Global Topical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Global Topical Hemostatic Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Topical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gelation Sponge Image Figure 9. Oxidized Regenerated Cellulose Based Hemostats Image Figure 10. Others Image Figure 11. Global Topical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Topical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Topical Hemostatic Agents Sales Market Share by Type (2021-2032) Figure 14. Global Topical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Topical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Topical Hemostatic Agents Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Nursing Homes Image Figure 19. Surgical Centers Image Figure 20. Global Topical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Topical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Topical Hemostatic Agents Sales Market Share by Application (2021-2032) Figure 23. Global Topical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Topical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Topical Hemostatic Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Topical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Topical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Topical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 40. China Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Topical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Topical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Topical Hemostatic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Topical Hemostatic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Topical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Topical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Topical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Topical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Topical Hemostatic Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Topical Hemostatic Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others
Applications
  • Hospitals
  • Nursing Homes
  • Surgical Centers
Companies covered
  • Pfizer
  • B Braun Melsungen
  • Baxter International
  • Vascular Solutions
  • The Medicines Company
  • Marine Polymer Technologies
  • Integra LifeSciences
  • Gelita Medical
  • Ethicon
  • Equimedical
  • C. R. Bard
  • Anika Therapeutics
  • Advanced Medical Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Topical Hemostatic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Topical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Topical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Topical Hemostatic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Topical Hemostatic Agents Market Dynamics
  1. 2.1 Topical Hemostatic Agents Industry Trends
  2. 2.2 Topical Hemostatic Agents Industry Drivers
  3. 2.3 Topical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Topical Hemostatic Agents Industry Restraints
3 Topical Hemostatic Agents Market by Manufacturers
  1. 3.1 Global Topical Hemostatic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Topical Hemostatic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Topical Hemostatic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Topical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Topical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Topical Hemostatic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Topical Hemostatic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Topical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Topical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Topical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Topical Hemostatic Agents Market by Type
  1. 4.1 Topical Hemostatic Agents Type Introduction
  2. 4.1.1 Gelation Sponge
  3. 4.1.2 Oxidized Regenerated Cellulose Based Hemostats
  4. 4.1.3 Others
  5. 4.2 Global Topical Hemostatic Agents Sales by Type
  6. 4.2.1 Global Topical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Topical Hemostatic Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Topical Hemostatic Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Topical Hemostatic Agents Revenue by Type
  10. 4.3.1 Global Topical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Topical Hemostatic Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Topical Hemostatic Agents Revenue Market Share by Type (2021-2032)
5 Topical Hemostatic Agents Market by Application
  1. 5.1 Topical Hemostatic Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Nursing Homes
  4. 5.1.3 Surgical Centers
  5. 5.2 Global Topical Hemostatic Agents Sales by Application
  6. 5.2.1 Global Topical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Topical Hemostatic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Topical Hemostatic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Topical Hemostatic Agents Revenue by Application
  10. 5.3.1 Global Topical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Topical Hemostatic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Topical Hemostatic Agents Revenue Market Share by Application (2021-2032)
6 Global Topical Hemostatic Agents Sales by Region
  1. 6.1 Global Topical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Topical Hemostatic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Topical Hemostatic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Topical Hemostatic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Topical Hemostatic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Topical Hemostatic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Topical Hemostatic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Topical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Topical Hemostatic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Topical Hemostatic Agents Revenue by Region
  1. 7.1 Global Topical Hemostatic Agents Revenue by Region
  2. 7.1.1 Global Topical Hemostatic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Topical Hemostatic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Topical Hemostatic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Topical Hemostatic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Topical Hemostatic Agents Revenue (2021-2032)
  8. 7.2.2 North America Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Topical Hemostatic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Topical Hemostatic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Topical Hemostatic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Topical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Topical Hemostatic Agents Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 B Braun Melsungen
  8. 8.2.1 B Braun Melsungen Company Information
  9. 8.2.2 B Braun Melsungen Business Overview
  10. 8.2.3 B Braun Melsungen Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 B Braun Melsungen Topical Hemostatic Agents Product Portfolio
  12. 8.2.5 B Braun Melsungen Recent Developments
  13. 8.3 Baxter International
  14. 8.3.1 Baxter International Company Information
  15. 8.3.2 Baxter International Business Overview
  16. 8.3.3 Baxter International Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter International Topical Hemostatic Agents Product Portfolio
  18. 8.3.5 Baxter International Recent Developments
  19. 8.4 Vascular Solutions
  20. 8.4.1 Vascular Solutions Company Information
  21. 8.4.2 Vascular Solutions Business Overview
  22. 8.4.3 Vascular Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vascular Solutions Topical Hemostatic Agents Product Portfolio
  24. 8.4.5 Vascular Solutions Recent Developments
  25. 8.5 The Medicines Company
  26. 8.5.1 The Medicines Company Company Information
  27. 8.5.2 The Medicines Company Business Overview
  28. 8.5.3 The Medicines Company Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 The Medicines Company Topical Hemostatic Agents Product Portfolio
  30. 8.5.5 The Medicines Company Recent Developments
  31. 8.6 Marine Polymer Technologies
  32. 8.6.1 Marine Polymer Technologies Company Information
  33. 8.6.2 Marine Polymer Technologies Business Overview
  34. 8.6.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio
  36. 8.6.5 Marine Polymer Technologies Recent Developments
  37. 8.7 Integra LifeSciences
  38. 8.7.1 Integra LifeSciences Company Information
  39. 8.7.2 Integra LifeSciences Business Overview
  40. 8.7.3 Integra LifeSciences Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Integra LifeSciences Topical Hemostatic Agents Product Portfolio
  42. 8.7.5 Integra LifeSciences Recent Developments
  43. 8.8 Gelita Medical
  44. 8.8.1 Gelita Medical Company Information
  45. 8.8.2 Gelita Medical Business Overview
  46. 8.8.3 Gelita Medical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gelita Medical Topical Hemostatic Agents Product Portfolio
  48. 8.8.5 Gelita Medical Recent Developments
  49. 8.9 Ethicon
  50. 8.9.1 Ethicon Company Information
  51. 8.9.2 Ethicon Business Overview
  52. 8.9.3 Ethicon Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ethicon Topical Hemostatic Agents Product Portfolio
  54. 8.9.5 Ethicon Recent Developments
  55. 8.10 Equimedical
  56. 8.10.1 Equimedical Company Information
  57. 8.10.2 Equimedical Business Overview
  58. 8.10.3 Equimedical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Equimedical Topical Hemostatic Agents Product Portfolio
  60. 8.10.5 Equimedical Recent Developments
  61. 8.11 C. R. Bard
  62. 8.11.1 C. R. Bard Company Information
  63. 8.11.2 C. R. Bard Business Overview
  64. 8.11.3 C. R. Bard Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 C. R. Bard Topical Hemostatic Agents Product Portfolio
  66. 8.11.5 C. R. Bard Recent Developments
  67. 8.12 Anika Therapeutics
  68. 8.12.1 Anika Therapeutics Company Information
  69. 8.12.2 Anika Therapeutics Business Overview
  70. 8.12.3 Anika Therapeutics Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Anika Therapeutics Topical Hemostatic Agents Product Portfolio
  72. 8.12.5 Anika Therapeutics Recent Developments
  73. 8.13 Advanced Medical Solutions
  74. 8.13.1 Advanced Medical Solutions Company Information
  75. 8.13.2 Advanced Medical Solutions Business Overview
  76. 8.13.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio
  78. 8.13.5 Advanced Medical Solutions Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Topical Hemostatic Agents Value Chain Analysis
  2. 9.1.1 Topical Hemostatic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Topical Hemostatic Agents Production Mode & Process
  6. 9.2 Topical Hemostatic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Topical Hemostatic Agents Distributors
  9. 9.2.3 Topical Hemostatic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst